Answers are grounded in this paper and cite their sources.
BACKGROUND: Artificial intelligence (AI) use by early-career paediatric endocrinologists has started without waiting for the training and governance structures to develop. Since early-career physicians and researchers of today hold no pre-AI performance baseline against which to appraise the AI outputs, career stage-specific concerns regarding rapid adoption of AI use in the field have emerged. The goal of this review was to examine AI use in paediatric endocrinology from the early-career perspective. SUMMARY: A narrative, non-systematic literature review regarding the AI use in paediatric endocrinology across the four professional domains (curricular coverage, clinical practice, teaching, and research) was conducted in January 2026 and updated through July 2026. 57 relevant publications were identified, with level of evidence differing significantly between domains, and inversely with how freely the AI tools are used: from randomised-trials data regarding specific clinical applications like closed-loop insulin delivery and automated bone age assessment, to no published data regarding use of large language models in the research domain. Greatest benefit of automated bone age assessment in the early career stage was reported, while no published studies examining AI use by early-career paediatric endocrinologists were found. KEY MESSAGES: While being most exposed to unsupervised AI use, early-career physicians are also the least studied group. Having in mind the lack of pre-AI baseline in this population, findings of this review emphasize the potential career stage-dependent risks regarding the AI use, and the need for subspecialty-specific AI competency frameworks.
No takes yet. Share an insight, caveat, or question.
Vuković et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: